Table 1.

Summary of socio-demographic variables from our patient population

Variable	Pilot phase and phase I	Phase I
	PRO-CTCAE administered in chemotherapy day hospital or clinic, N = 497	Patient had any severe symptom as defined by having at least score 3 or 4 on any PRO-CTCAE item, N = 195	Patients reached for post-outpatient visit telephone survey, N = 119
Age (median, range)	56 (18–99)	56 (19–85)	54 (19–85)
Gender (%male)	42%	39%	32%
Ethnicity (%Caucasian)	70%	74%	76%
% married	73%	68%	72%
% with any post-secondary education	72%	74%	77%
% employed currently	49%	49%	50%
Household income
< $75 K	33%	29%	30%
$75 to < $100 K	13%	13%	14%
$100 K+	23%	24%	22%
Primary site of disease
Gastrointestinal	18%	9%	11%
Genitourinary	10%	12%	11%
Gynecological	12%	8%	6%
Breast	19%	20%	18%
Thoracic	16%	21%	18%
Head and neck	12%	15%	18%
Hematologic	13%	15%	18%
Intent of treatment
Curative	35%	30%	30%
Palliative	53%	55%	52%
Hematologica	12%	15%	18%

All values represent percentages of patients except age. The smaller samples represent a subset of the patients in each of the larger datasets

^aHematologic cancers often are not described as either curative or palliative, and thus are listed separately